dc.contributor.author | Villarreal Garza, Cynthia | |
dc.contributor.author | Lopez Martinez, Edna Anakarenn | |
dc.contributor.author | Deneken Hernandez, Zuratzi | |
dc.contributor.author | Maffuz Aziz, Antonio | |
dc.contributor.author | Muñoz Lozano, Jose Felipe | |
dc.contributor.author | Barragan Carrillo, Regina | |
dc.contributor.author | Ramos Elias, Pier | |
dc.contributor.author | Moreno, Brizio | |
dc.contributor.author | Diaz Perez, Hector | |
dc.contributor.author | Peña Curiel, Omar | |
dc.contributor.author | Curiel Valdez, Jose de Jesus | |
dc.contributor.author | Bautista Piña, Veronica | |
dc.date.accessioned | 2022-06-29T22:27:46Z | |
dc.date.available | 2022-06-29T22:27:46Z | |
dc.date.issued | 2020-03-11 | |
dc.identifier.citation | Villarreal-Garza C, Lopez-Martinez EA, Deneken-Hernandez Z, Maffuz-Aziz A, Muñoz-Lozano JF, Barragan-Carrillo R, et al. (2020) Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients. PLoS ONE 15(3): e0228884. https://doi.org/10.1371/journal.pone.0228884 | es_MX |
dc.identifier.doi | https://doi.org/10.1371/journal.pone.0228884 | |
dc.identifier.uri | https://hdl.handle.net/11285/648507 | |
dc.description.abstract | To evaluate the change in adjuvant therapeutic decision in a cohort of young women with breast cancer discussed by a multidisciplinary team, before and after EndoPredict testing. | es_MX |
dc.format.medium | Texto | es_MX |
dc.language.iso | eng | es_MX |
dc.relation.isFormatOf | publishedVersion | es_MX |
dc.relation.url | https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0228884 | es_MX |
dc.rights | openAccess | es_MX |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | es_MX |
dc.subject | MEDICINA Y CIENCIAS DE LA SALUD::CIENCIAS MÉDICAS::CIENCIAS CLÍNICAS::ONCOLOGÍA | es_MX |
dc.subject.lcsh | Medicine | es_MX |
dc.title | Change in therapeutic management after the EndoPredict assay in a prospective decision impact study of Mexican premenopausal breast cancer patients | es_MX |
dc.type | Artículo/Article | es_MX |
dc.identifier.journal | PLoS ONE | es_MX |
dc.subject.keyword | Cancer treatment | es_MX |
dc.subject.keyword | Breast cancer | es_MX |
dc.subject.keyword | Cancers and neoplasms | es_MX |
dc.subject.keyword | Cancer chemotherapy | es_MX |
dc.subject.keyword | Endocrine therapy | es_MX |
dc.subject.keyword | Oncology | es_MX |
dc.subject.keyword | Cancer risk factors | es_MX |
dc.subject.keyword | Decision making | es_MX |
dc.identifier.volume | 15 | es_MX |
dc.identifier.issue | 3 | es_MX |
dc.contributor.affiliation | Instituto Tecnológico y de Estudios Superiores de Monterrey | es_MX |
dc.subject.country | Estados Unidos de América / United States | es_MX |
dc.identificator | 3||32||3201||320101 | es_MX |